Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiotherapy Planning, Computer-Assisted | 26 | 2013 | 1622 | 2.220 |
Why?
|
| Movement | 23 | 2011 | 1470 | 1.850 |
Why?
|
| Respiration | 21 | 2011 | 1645 | 1.800 |
Why?
|
| Four-Dimensional Computed Tomography | 5 | 2013 | 145 | 1.330 |
Why?
|
| Radiotherapy, Conformal | 10 | 2009 | 548 | 1.310 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 8 | 2013 | 1183 | 0.970 |
Why?
|
| Lung Neoplasms | 20 | 2011 | 13019 | 0.700 |
Why?
|
| Phantoms, Imaging | 12 | 2011 | 2466 | 0.690 |
Why?
|
| Imaging, Three-Dimensional | 11 | 2010 | 4029 | 0.600 |
Why?
|
| Tomography, X-Ray Computed | 19 | 2010 | 20086 | 0.560 |
Why?
|
| Radiotherapy, High-Energy | 1 | 2013 | 228 | 0.450 |
Why?
|
| Thoracic Neoplasms | 2 | 2013 | 268 | 0.450 |
Why?
|
| X-Ray Film | 1 | 2012 | 33 | 0.430 |
Why?
|
| X-Ray Intensifying Screens | 1 | 2012 | 32 | 0.430 |
Why?
|
| Artifacts | 6 | 2010 | 1903 | 0.390 |
Why?
|
| Linoleic Acids | 1 | 2010 | 38 | 0.370 |
Why?
|
| Protons | 3 | 2011 | 1126 | 0.370 |
Why?
|
| Radiotherapy, Computer-Assisted | 3 | 2011 | 94 | 0.360 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2010 | 85 | 0.350 |
Why?
|
| Radiotherapy | 5 | 2010 | 1525 | 0.350 |
Why?
|
| Organs at Risk | 1 | 2011 | 346 | 0.350 |
Why?
|
| Fluoroscopy | 3 | 2011 | 924 | 0.340 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 2010 | 226 | 0.340 |
Why?
|
| Monte Carlo Method | 3 | 2011 | 1254 | 0.320 |
Why?
|
| Radiographic Image Enhancement | 5 | 2010 | 885 | 0.310 |
Why?
|
| Liver Neoplasms | 6 | 2011 | 4249 | 0.310 |
Why?
|
| Respiratory Mechanics | 3 | 2010 | 681 | 0.300 |
Why?
|
| Radiotherapy Dosage | 12 | 2013 | 2876 | 0.300 |
Why?
|
| Thromboxane B2 | 1 | 2006 | 152 | 0.280 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2008 | 534 | 0.270 |
Why?
|
| Documentation | 1 | 2012 | 865 | 0.270 |
Why?
|
| Viscera | 1 | 2006 | 139 | 0.270 |
Why?
|
| Photogrammetry | 1 | 2006 | 73 | 0.270 |
Why?
|
| Radiometry | 4 | 2009 | 800 | 0.270 |
Why?
|
| Abdomen | 1 | 2011 | 1107 | 0.260 |
Why?
|
| Lipid Peroxidation | 1 | 2006 | 270 | 0.260 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 6 | 2010 | 5171 | 0.250 |
Why?
|
| Motion | 5 | 2010 | 797 | 0.230 |
Why?
|
| Abdominal Neoplasms | 1 | 2005 | 290 | 0.230 |
Why?
|
| Tomography, Spiral Computed | 1 | 2004 | 279 | 0.210 |
Why?
|
| Pattern Recognition, Automated | 2 | 2006 | 996 | 0.210 |
Why?
|
| Guideline Adherence | 1 | 2012 | 2266 | 0.200 |
Why?
|
| Sensitivity and Specificity | 10 | 2013 | 14720 | 0.200 |
Why?
|
| Respiratory-Gated Imaging Techniques | 2 | 2010 | 71 | 0.180 |
Why?
|
| Software | 4 | 2008 | 4434 | 0.180 |
Why?
|
| Algorithms | 13 | 2010 | 13853 | 0.170 |
Why?
|
| Nitrosamines | 2 | 2010 | 87 | 0.170 |
Why?
|
| Reproducibility of Results | 12 | 2013 | 19862 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2006 | 1434 | 0.170 |
Why?
|
| Radiology | 1 | 2012 | 2090 | 0.160 |
Why?
|
| Breast Neoplasms | 4 | 2010 | 20774 | 0.150 |
Why?
|
| Nuclear Physics | 1 | 2017 | 79 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2008 | 8925 | 0.150 |
Why?
|
| Particle Accelerators | 3 | 2008 | 173 | 0.140 |
Why?
|
| Surgical Instruments | 2 | 2010 | 394 | 0.140 |
Why?
|
| Pancreatic Neoplasms | 2 | 2011 | 5249 | 0.140 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2006 | 3328 | 0.130 |
Why?
|
| Electronic Health Records | 1 | 2012 | 4440 | 0.130 |
Why?
|
| Artificial Intelligence | 2 | 2006 | 2187 | 0.130 |
Why?
|
| X-Rays | 3 | 2005 | 301 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 7276 | 0.130 |
Why?
|
| Diagnostic Imaging | 1 | 2008 | 3507 | 0.120 |
Why?
|
| Computer Simulation | 2 | 2005 | 6191 | 0.120 |
Why?
|
| Radiotherapy, Intensity-Modulated | 2 | 2010 | 806 | 0.110 |
Why?
|
| Water | 2 | 2009 | 1388 | 0.100 |
Why?
|
| Michigan | 1 | 2012 | 350 | 0.100 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2011 | 101 | 0.100 |
Why?
|
| Humans | 44 | 2013 | 742088 | 0.100 |
Why?
|
| Carcinoma, Large Cell | 2 | 2010 | 113 | 0.100 |
Why?
|
| Smoking | 1 | 2008 | 8969 | 0.100 |
Why?
|
| Lung | 5 | 2010 | 9826 | 0.090 |
Why?
|
| Fiducial Markers | 1 | 2011 | 136 | 0.090 |
Why?
|
| Mice, Inbred A | 1 | 2010 | 248 | 0.090 |
Why?
|
| Breast | 2 | 2009 | 1958 | 0.090 |
Why?
|
| Scintillation Counting | 1 | 2009 | 38 | 0.080 |
Why?
|
| Radiography | 3 | 2009 | 7010 | 0.080 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 1 | 2008 | 23 | 0.080 |
Why?
|
| Radiography, Abdominal | 1 | 2011 | 537 | 0.080 |
Why?
|
| Models, Biological | 1 | 2005 | 9581 | 0.080 |
Why?
|
| Technology, Radiologic | 1 | 2008 | 163 | 0.080 |
Why?
|
| Mammography | 2 | 2009 | 2474 | 0.070 |
Why?
|
| Stomach | 1 | 2011 | 697 | 0.070 |
Why?
|
| Radiography, Thoracic | 1 | 2013 | 1265 | 0.070 |
Why?
|
| Uncertainty | 2 | 2010 | 725 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2010 | 493 | 0.070 |
Why?
|
| Staurosporine | 1 | 2008 | 251 | 0.070 |
Why?
|
| Exhalation | 1 | 2007 | 166 | 0.070 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2006 | 46 | 0.070 |
Why?
|
| Organ Size | 1 | 2011 | 2253 | 0.070 |
Why?
|
| Body Burden | 1 | 2006 | 158 | 0.070 |
Why?
|
| Thoracic Wall | 1 | 2008 | 201 | 0.070 |
Why?
|
| Quality Control | 1 | 2008 | 841 | 0.070 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2010 | 448 | 0.070 |
Why?
|
| Equipment Design | 3 | 2009 | 3582 | 0.070 |
Why?
|
| Caspase 3 | 1 | 2008 | 759 | 0.070 |
Why?
|
| Statistical Distributions | 1 | 2005 | 64 | 0.060 |
Why?
|
| Calibration | 1 | 2008 | 815 | 0.060 |
Why?
|
| Subtraction Technique | 2 | 2006 | 525 | 0.060 |
Why?
|
| Female | 15 | 2013 | 379592 | 0.060 |
Why?
|
| Aged, 80 and over | 5 | 2013 | 57683 | 0.060 |
Why?
|
| Relative Biological Effectiveness | 1 | 2006 | 323 | 0.060 |
Why?
|
| Iridium Radioisotopes | 1 | 2003 | 26 | 0.060 |
Why?
|
| Time Factors | 6 | 2010 | 40054 | 0.060 |
Why?
|
| Models, Statistical | 4 | 2009 | 5100 | 0.060 |
Why?
|
| Dose-Response Relationship, Radiation | 4 | 2005 | 876 | 0.050 |
Why?
|
| Yttrium Radioisotopes | 1 | 2003 | 93 | 0.050 |
Why?
|
| Hair Follicle | 1 | 2004 | 209 | 0.050 |
Why?
|
| Mastectomy, Segmental | 1 | 2008 | 955 | 0.050 |
Why?
|
| Intestines | 1 | 2011 | 1923 | 0.050 |
Why?
|
| Biophysical Phenomena | 1 | 2003 | 327 | 0.050 |
Why?
|
| Aged | 9 | 2013 | 162944 | 0.050 |
Why?
|
| Diaphragm | 1 | 2004 | 347 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2005 | 11039 | 0.050 |
Why?
|
| Biophysics | 1 | 2003 | 383 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 2885 | 0.050 |
Why?
|
| Cranial Irradiation | 1 | 2004 | 401 | 0.050 |
Why?
|
| Principal Component Analysis | 1 | 2005 | 939 | 0.050 |
Why?
|
| Tumor Burden | 1 | 2007 | 1905 | 0.050 |
Why?
|
| Dura Mater | 1 | 2003 | 291 | 0.050 |
Why?
|
| Models, Anatomic | 1 | 2005 | 690 | 0.050 |
Why?
|
| Male | 13 | 2013 | 349538 | 0.050 |
Why?
|
| Neoplasms | 3 | 2004 | 21596 | 0.050 |
Why?
|
| Alopecia | 1 | 2004 | 381 | 0.050 |
Why?
|
| Posture | 1 | 2004 | 958 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2010 | 2940 | 0.040 |
Why?
|
| Middle Aged | 8 | 2013 | 213127 | 0.040 |
Why?
|
| Information Storage and Retrieval | 1 | 2005 | 824 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2008 | 2128 | 0.040 |
Why?
|
| Dogs | 1 | 2004 | 3910 | 0.040 |
Why?
|
| Photons | 1 | 2003 | 587 | 0.040 |
Why?
|
| Liver | 2 | 2011 | 7470 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2010 | 3691 | 0.040 |
Why?
|
| Switzerland | 1 | 2017 | 254 | 0.040 |
Why?
|
| Radiation Oncology | 1 | 2003 | 554 | 0.040 |
Why?
|
| Spinal Neoplasms | 1 | 2003 | 759 | 0.030 |
Why?
|
| Feasibility Studies | 4 | 2009 | 5062 | 0.030 |
Why?
|
| Kidney | 1 | 2011 | 7167 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2010 | 11001 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2010 | 5163 | 0.030 |
Why?
|
| Brachytherapy | 1 | 2003 | 1246 | 0.030 |
Why?
|
| Heart | 1 | 2007 | 4462 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2005 | 2921 | 0.030 |
Why?
|
| Disease Progression | 1 | 2010 | 13256 | 0.030 |
Why?
|
| Treatment Outcome | 4 | 2013 | 62966 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 18006 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2017 | 1533 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 11472 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2011 | 77098 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2017 | 2739 | 0.020 |
Why?
|
| Solutions | 1 | 2009 | 426 | 0.020 |
Why?
|
| Silicones | 1 | 2009 | 248 | 0.020 |
Why?
|
| Computer Systems | 1 | 2009 | 483 | 0.020 |
Why?
|
| Computer-Aided Design | 1 | 2009 | 298 | 0.020 |
Why?
|
| Nipples | 1 | 2009 | 216 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2009 | 867 | 0.020 |
Why?
|
| Surface Properties | 1 | 2009 | 1182 | 0.020 |
Why?
|
| Mutation | 1 | 2010 | 29717 | 0.020 |
Why?
|
| Animals | 2 | 2010 | 168561 | 0.020 |
Why?
|
| Systole | 1 | 2007 | 956 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2010 | 1758 | 0.020 |
Why?
|
| Diastole | 1 | 2007 | 791 | 0.020 |
Why?
|
| Exons | 1 | 2010 | 2431 | 0.020 |
Why?
|
| Mice | 1 | 2010 | 81045 | 0.010 |
Why?
|
| Lasers | 1 | 2005 | 952 | 0.010 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2003 | 281 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6171 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 2003 | 766 | 0.010 |
Why?
|
| Radiation Injuries | 1 | 2006 | 1178 | 0.010 |
Why?
|
| Thoracic Vertebrae | 1 | 2003 | 604 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2005 | 2372 | 0.010 |
Why?
|
| Cholangiocarcinoma | 1 | 2004 | 516 | 0.010 |
Why?
|
| Adult | 2 | 2008 | 213712 | 0.010 |
Why?
|
| Survival Rate | 1 | 2010 | 12773 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 6365 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2010 | 4029 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 7901 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 2003 | 1844 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2010 | 6347 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2003 | 2217 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2004 | 3584 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 8621 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2005 | 6259 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2003 | 39004 | 0.000 |
Why?
|
Concepts
(183)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_